Universal-Beteiligungs- und Servicegesellschaft
REGN icon

Universal-Beteiligungs- und Servicegesellschaft’s Regeneron Pharmaceuticals REGN Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.7M Sell
100,286
-9,434
-9% -$6.42M 0.1% 174
2026
Q1 		$84.9M Buy
109,720
+849
+0.8% +$650K 0.15% 127
2025
Q4 		$84.2M Buy
108,871
+827
+0.8% +$562K 0.14% 134
2025
Q3 		$60.7M Buy
108,044
+1,486
+1% +$840K 0.1% 179
2025
Q2 		$55.9M Sell
106,558
-50,695
-32% -$28.3M 0.1% 187
2025
Q1 		$99.7M Sell
157,253
-21,337
-12% -$14.7M 0.2% 105
2024
Q4 		$127M Buy
+178,590
New +$150M 0.25% 78

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's REGN Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Regeneron Pharmaceuticals (REGN) stake by 8.6% in Q2 2026, selling an estimated $6.42M and leaving 100,286 shares worth $62.7M. The position accounts for 0.1% of the portfolio, ranked #174.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $127M in Q4 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 100,286 shares of Regeneron Pharmaceuticals worth $62.7M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 9,434 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $6.42M.
  • Regeneron Pharmaceuticals made up 0.1% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #174 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Regeneron Pharmaceuticals position peaked at $127M in Q4 2024.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.